Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arrhythmias and cardiac devices management in oncology patients.

Heart rhythm·2026
Same author

A call to action for an innovative and integrative approach to persistent atrial fibrillation: Perspectives from the Heart Rhythm Society Emerging Leaders Think Tank.

Heart rhythm·2025
Same author

The State of the Cardiac Electrophysiology Workforce in the United States: Projections, Challenges, and Keeping Pace With Clinical Demands.

JACC. Clinical electrophysiology·2025
Same author

State of the art of mobile health technologies use in clinical arrhythmia care.

Communications medicine·2024
Same author

Management of anesthesia for procedures in the cardiac electrophysiology laboratory.

Heart rhythm·2024
Same author

Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review.

Journal of the American College of Cardiology·2024
Same journal

The Heart of the Metaverse: How Immersive Technologies Are Revolutionizing Cardiac Care.

IEEE pulse·2026
Same journal

Benefits for Early Diagnosis, Treatment, and Research.

IEEE pulse·2026
Same journal

At the Crossroads of Innovation.

IEEE pulse·2026
Same journal

Robotics in the Cath Lab: Precision, Safety, and the Rise of Remote Cardiac Interventions.

IEEE pulse·2026
Same journal

Industry Corner Live With BioBeat CEO Arik Ben Ishay.

IEEE pulse·2026
Same journal

Engineering the Next Generation of Artificial Hearts.

IEEE pulse·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

SafeBeat Rx-Moving ECG AI Beyond Diagnostics to Recommending Treatment.

Rachita Navara, Margaret Ferari, Walker McHugh

    IEEE Pulse
    |June 12, 2026
    PubMed
    Summary
    This summary is machine-generated.

    SafeBeat Rx, an AI-powered ECG platform, improves drug safety by accurately measuring QT intervals, addressing a key concern in medication approvals and cardiac surveillance.

    More Related Videos

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
    10:17

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

    Published on: April 11, 2025

    Related Experiment Videos

    Last Updated: Jun 14, 2026

    A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
    18:11

    A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

    Published on: December 28, 2012

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
    10:17

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

    Published on: April 11, 2025

    Area of Science:

    • Cardiology
    • Artificial Intelligence
    • Pharmacology

    Background:

    • Drug-induced QT prolongation is a major reason for FDA drug nonapproval and a safety concern for various medications.
    • Existing automated QT measurement algorithms struggle with irregular ECGs, leading to high misclassification rates up to 75%.

    Purpose of the Study:

    • To introduce SafeBeat Rx, an AI-powered ECG platform designed for precise, beat-by-beat QT interval analysis.
    • To enhance the reliability of QT measurements for improved drug safety and cardiac surveillance.

    Main Methods:

    • Development of an AI-powered ECG analysis platform (SafeBeat Rx).
    • Implementation of beat-by-beat ECG analysis with adjustable measurement parameters.
    • Validation of the platform against expert cardiologist adjudication.

    Main Results:

    • SafeBeat Rx provides transparent, beat-by-beat ECG analysis.
    • The platform demonstrated accuracy validated by expert cardiologists.
    • It offers adjustable measurements for individual ECG heartbeats.

    Conclusions:

    • SafeBeat Rx offers a novel solution for accurate QT interval measurement, crucial for drug safety.
    • The platform addresses limitations in current automated QT analysis, particularly for complex ECGs.
    • SafeBeat Rx enhances post-discharge cardiac surveillance and supports guideline-adherent pharmacological management.